Get the content you want anytime you want.

Local Infectious Disease Response Efforts Receive $200 Million Boost from CDC

In addition, part of the $77 million will be used to expand on the CDC’s PulseNet, which tracks food-borne illnesses. State-level public health labs will “work toward performing WGS on food and waterborne bacteria, including Salmonella, Shigella, and Campylobacter.”

Carbapenem-resistant Enterobacteriaceae (CRE) will continue to be tested for in all 50 states, including 6 major cities (Chicago, the District of Columbia, Houston, Los Angeles County, New York City, and Philadelphia), and in Puerto Rico.

According to the press release, funding from the ELC is also being used to provide “resources for other infectious disease control activities, including supporting states’ continued vigilance against Zika.” The CDC has already provided over $300 million to state, local, and territorial health departments in fiscal year 2017; $100.8 of which were part of a “supplemental, one-time investment to fight Zika.”

The remaining 2017 funding, a total of $124 million, will go to more than 40 projects, including those to:
  • Enhance influenza surveillance and diagnostic testing, parasitic diseases, tick-borne diseases, West Nile virus and other mosquito-borne diseases, food-borne diseases, water-borne disease detection
  • Establish and maintain local, state, and territorial health coordinators to track vaccine-preventable diseases like measles and pertussis.
  • Help states build their capacity for Advanced Molecular Detection, an emerging field that combines next-generation genomic sequencing with bioinformatics to more quickly identify and respond to disease outbreaks
  • Protect the public health and safety of the American people by strengthening cross-cutting national surveillance, boosting laboratory infrastructure with the latest diagnostic technologies, and enhancing health information systems to efficiently transmit, receive, and analyze infectious disease-related data electronically.
  • Support states’ continued vigilance against Zika virus outbreaks and associated adverse health outcomes, including microcephaly and other serious birth defects.
To stay informed on the latest in infectious disease news and developments, please sign up for our weekly newsletter.

Big advances in treatment can